Pages

Wednesday, July 3, 2013

Sandoz launches generic metronidazole in the US

Sandoz has launched metronidazole 1% topical gel, the first generic version of METROGEL® 1%.

Metronidazole 1% topical gel is indicated for the topical treatment of inflammatory lesions of rosacea. According
to IMS Health, US sales for branded metronidazole 1% topical gel were
USD 110 million for the 12 months ending in April 2013. Galderma is the innovator for Metronidazole.With Sandoz being the only player on the market, we expect it to garner about 40 percent market share a ta price discount of 40 percent in 2013. This should add about $30m to Sandoz sales.

Archive

Disclaimer

The article or comments posted on this blog is solely the opinion of the authors contributing to the site. We do not take any responsibility of any loss or for any harm or damages arising from the content or material posted on this blog